121 related articles for article (PubMed ID: 31542517)
1. Precision detection of liver metastasis by collagen-targeted protein MRI contrast agent.
Salarian M; Yang H; Turaga RC; Tan S; Qiao J; Xue S; Gui Z; Peng G; Han H; Mittal P; Grossniklaus HE; Yang JJ
Biomaterials; 2019 Dec; 224():119478. PubMed ID: 31542517
[TBL] [Abstract][Full Text] [Related]
2. Early detection and staging of chronic liver diseases with a protein MRI contrast agent.
Salarian M; Turaga RC; Xue S; Nezafati M; Hekmatyar K; Qiao J; Zhang Y; Tan S; Ibhagui OY; Hai Y; Li J; Mukkavilli R; Sharma M; Mittal P; Min X; Keilholz S; Yu L; Qin G; Farris AB; Liu ZR; Yang JJ
Nat Commun; 2019 Oct; 10(1):4777. PubMed ID: 31664017
[TBL] [Abstract][Full Text] [Related]
3. Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging.
Xue S; Yang H; Qiao J; Pu F; Jiang J; Hubbard K; Hekmatyar K; Langley J; Salarian M; Long RC; Bryant RG; Hu XP; Grossniklaus HE; Liu ZR; Yang JJ
Proc Natl Acad Sci U S A; 2015 May; 112(21):6607-12. PubMed ID: 25971726
[TBL] [Abstract][Full Text] [Related]
4. Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging.
Li D; Kirberger M; Qiao J; Gui Z; Xue S; Pu F; Jiang J; Xu Y; Tan S; Salarian M; Ibhagui O; Hekmatyar K; Yang JJ
Invest Radiol; 2024 Feb; 59(2):170-186. PubMed ID: 38180819
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive detection and complementary diagnosis of liver metastases via chemokine receptor 4 imaging.
Yang H; Tan S; Qiao J; Xu Y; Gui Z; Meng Y; Dong B; Peng G; Ibhagui OY; Qian W; Lu J; Li Z; Wang G; Lai J; Yang L; Grossniklaus HE; Yang JJ
Cancer Gene Ther; 2022 Dec; 29(12):1827-1839. PubMed ID: 35145271
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases.
Tan S; Yang H; Xue S; Qiao J; Salarian M; Hekmatyar K; Meng Y; Mukkavilli R; Pu F; Odubade OY; Harris W; Hai Y; Yushak ML; Morales-Tirado VM; Mittal P; Sun PZ; Lawson D; Grossniklaus HE; Yang JJ
Sci Adv; 2020 Feb; 6(6):eaav7504. PubMed ID: 32083172
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.
Pu F; Salarian M; Xue S; Qiao J; Feng J; Tan S; Patel A; Li X; Mamouni K; Hekmatyar K; Zou J; Wu D; Yang JJ
Nanoscale; 2016 Jul; 8(25):12668-82. PubMed ID: 26961235
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. [MR imaging of liver metastasis using Gd-EOB-DTPA].
Kuwatsuru R
Gan To Kagaku Ryoho; 2009 Aug; 36(8):1234-41. PubMed ID: 19692760
[TBL] [Abstract][Full Text] [Related]
11. Enhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent.
Zhou X; Ye M; Han Y; Tang J; Qian Y; Hu H; Shen Y
Biomater Sci; 2017 Jul; 5(8):1588-1595. PubMed ID: 28422200
[TBL] [Abstract][Full Text] [Related]
12. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
[TBL] [Abstract][Full Text] [Related]
13. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
14. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
[TBL] [Abstract][Full Text] [Related]
15. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
Kuo YT; Chen CY; Liu GC; Wang YM
PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
[TBL] [Abstract][Full Text] [Related]
16. MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.
Zhou Z; Qutaish M; Han Z; Schur RM; Liu Y; Wilson DL; Lu ZR
Nat Commun; 2015 Aug; 6():7984. PubMed ID: 26264658
[TBL] [Abstract][Full Text] [Related]
17. The effect of metal ions on endogenous melanin nanoparticles used as magnetic resonance imaging contrast agents.
Chen A; Sun J; Liu S; Li L; Peng X; Ma L; Zhang R
Biomater Sci; 2020 Jan; 8(1):379-390. PubMed ID: 31728481
[TBL] [Abstract][Full Text] [Related]
18. Albumin-Mediated Biomineralization of Paramagnetic NIR Ag2S QDs for Tiny Tumor Bimodal Targeted Imaging in Vivo.
Zhang J; Hao G; Yao C; Yu J; Wang J; Yang W; Hu C; Zhang B
ACS Appl Mater Interfaces; 2016 Jul; 8(26):16612-21. PubMed ID: 27300300
[TBL] [Abstract][Full Text] [Related]
19. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
